Lucía Alonso Buznego

Marqués de Valdecilla University Hospital — Spain

Medicine · Health Sciences

8h-index348citations20works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(12), Urinary and Genital Oncology Studies(11), Cancer Immunotherapy and Biomarkers(10), Retinal Diseases and Treatments(2), Microbial Inactivation Methods(2)

Publications20 total

Conjunctival and cutaneous Kaposi's Sarcoma as the first manifestation of HIV infection
Revista Española de Quimioterapia·2025Open Access
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes
Clinical Genitourinary Cancer·2025· 2 cited
Recurrence rate and quality of life in women with borderline ovarian tumours, according to surgical approach
European Journal of Obstetrics & Gynecology and Reproductive Biology·2025
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer·2024· 1 cited
Role of tumor mutational burden (TMB) and microsatellite instability (MSI) in patients (pts) with advanced urothelial carcinoma (aUC) treated with immune checkpoint inhibitor (ICI).
Journal of Clinical Oncology·2024· 2 cited
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience
Clinical Genitourinary Cancer·2023· 26 citedOpen Access
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer·2022· 9 citedOpen Access
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer·2022· 25 citedOpen Access
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin
Clinical Genitourinary Cancer·2021· 6 citedOpen Access
Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer
British Journal of Urology·2021· 5 citedOpen Access
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes
British Journal of Urology·2021· 27 citedOpen Access
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
European Urology Oncology·2021· 60 citedOpen Access
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study
The Journal of Urology·2020· 58 citedOpen Access
Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors
Cancer·2019· 89 citedOpen Access
Accelerated partial breast irradiation in a single 18 Gy fraction with high-dose-rate brachytherapy: preliminary results
Journal of Contemporary Brachytherapy·2018· 35 citedOpen Access
Disseminated maculo-papular lesions in a patient in contact with cattle
Enfermedades infecciosas y microbiologia clinica (English ed )·2017
Lesiones máculo-papulosas diseminadas en paciente en contacto con ganado
Enfermedades Infecciosas y Microbiología Clínica·2016
Síndrome de Horner tras amigdalectomía
Archivos de la Sociedad Española de Oftalmología·2008· 2 citedOpen Access
Fuga de triamcinolona intravítrea a cámara anterior
Archivos de la Sociedad Española de Oftalmología·2007· 1 citedOpen Access
FUGA DE TRIAMCINOLONA INTRAVÍTREA A CÁMARA ANTERIOR LEAK OF INTRAVITREAL TRIAMCINOLONE TO THE ANTERIOR CHAMBER
2007

Frequent Co-authors

Ali Raza Khaki(12), Leonidas Nikolaos Diamantopoulos(12), Rafael Morales‐Barrera(12), Petros Grivas(12), David J. Pinato(11), Ignacio Durán(11), Yousef Zakharia(11), Alejo Rodríguez‐Vida(10), Jure Murgić(10), Evan Y. Yu(10), Tyler F. Stewart(10), Daniel Castellano(9), Vadim S. Koshkin(9), Aristotelis Bamias(9), Mehmet Asım Bilen(8), Michael Devitt(8), Ariel Ann Nelson(8), Christopher Hoimes(8), Benjamin A. Gartrell(8), Alex Sankin(8)